Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05633888 · ClinicalTrials.gov registry record · NA
Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
A NA study of Sacroiliac Joint Disruption and Degenerative Sacroiliitis, sponsored by Tenon Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 6
- Study locations
NCT05633888 is a NA study of Sacroiliac Joint Disruption and Degenerative Sacroiliitis that is actively recruiting participants, run by Tenon Medical. The registered enrollment target is 50 participants. The trial reports 6 study locations across 6 states.
The verdict
NCT05633888, a NA study of Sacroiliac Joint Disruption and Degenerative Sacroiliitis, is actively recruiting participants, sponsored by Tenon Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.
Conditions Studied
Interventions
- DEVICE CATAMARAN SI Joint Fusion System
Study Locations (6)
Idaho
- Northwest Specialty Hospital - Coeur d'Alene
Indiana
- Comprehensive Pain and Spine Specialists - Muncie
Kentucky
- Vitality Pain Centers - Louisville
Minnesota
- Orthopedic Associates of Duluth - Duluth
Missouri
- St. Louis Pain Consultants - Chesterfield
Utah
- St. George Orthopedic Spine - St. George
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-11-14 |
| Est. Completion | 2026-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05633888
The ClinicalTrials.gov registry entry for NCT05633888 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tenon Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sacroiliac Joint Disruption appearing as the primary indexed condition, and to 1 intervention - of which CATAMARAN SI Joint Fusion System is the first listed.
NCT05633888 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Idaho, Indiana, Kentucky.
Frequently Asked Questions
What is clinical trial NCT05633888 about?
NCT05633888 is a clinical study titled "Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System". The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.
What is the current status of trial NCT05633888?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-11-14. Estimated completion is 2026-01.
What conditions does trial NCT05633888 study?
This clinical trial studies the following conditions: Sacroiliac Joint Disruption, Degenerative Sacroiliitis.
What interventions are being tested in trial NCT05633888?
The interventions under investigation include: CATAMARAN SI Joint Fusion System (DEVICE).
Who is sponsoring clinical trial NCT05633888?
This trial is sponsored by Tenon Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05633888 being conducted?
This trial has 6 study locations across Idaho, Indiana, Kentucky, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.